BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:872-880.e1. [PMID: 31302306 DOI: 10.1016/j.cgh.2019.06.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Hamdeh S, Micic D, Hanauer S. Drug-Induced Colitis. Clinical Gastroenterology and Hepatology 2021;19:1759-79. [DOI: 10.1016/j.cgh.2020.04.069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Williams AJ. Advanced therapies in inflammatory bowel disease: Special considerations. J Gastroenterol Hepatol 2021;36 Suppl 1:22-4. [PMID: 33817851 DOI: 10.1111/jgh.15454] [Reference Citation Analysis]
3 Rustgi SD, Kayal M, Shah SC. Sex-based differences in inflammatory bowel diseases: a review. Therap Adv Gastroenterol. 2020;13:1756284820915043. [PMID: 32523620 DOI: 10.1177/1756284820915043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Juvale IIA, Hassan Z, Has ATC. The Emerging Roles of π Subunit-Containing GABAA Receptors in Different Cancers. Int J Med Sci 2021;18:3851-60. [PMID: 34790061 DOI: 10.7150/ijms.60928] [Reference Citation Analysis]